Cite
Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.
MLA
Yoshimura, Makoto, et al. “Z-505 Hydrochloride, an Orally Active Ghrelin Agonist, Attenuates the Progression of Cancer Cachexia via Anabolic Hormones in Colon 26 Tumor-Bearing Mice.” European Journal of Pharmacology, vol. 811, Sept. 2017, pp. 30–37. EBSCOhost, https://doi.org/10.1016/j.ejphar.2017.05.036.
APA
Yoshimura, M., Shiomi, Y., Ohira, Y., Takei, M., & Tanaka, T. (2017). Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice. European Journal of Pharmacology, 811, 30–37. https://doi.org/10.1016/j.ejphar.2017.05.036
Chicago
Yoshimura, Makoto, Yoshihiro Shiomi, Yuta Ohira, Mineo Takei, and Takao Tanaka. 2017. “Z-505 Hydrochloride, an Orally Active Ghrelin Agonist, Attenuates the Progression of Cancer Cachexia via Anabolic Hormones in Colon 26 Tumor-Bearing Mice.” European Journal of Pharmacology 811 (September): 30–37. doi:10.1016/j.ejphar.2017.05.036.